Clinical Study
Narrow-Band Ultraviolet B versus Oral Minocycline in Treatment of Unstable Vitiligo: A Prospective Comparative Trial
Table 2
Demographics and disease parameters of the 42 patients.
| | | NB-UVB | Minocycline |
| | Number of patients | 21 | 21 | | Age in years (mean ± SD) | 27.6 ± 9.4 | 25.4 ± 10.3 | | Sex (male/female) | 8/13 | 10/11 | | Duration of disease before commencing therapy in years (mean ± SD) | 15.13 ± 6.30 | 9.76 ± 3.84 | | Positive family history | 2 | 4 | | Skin type | | | | Type 3 (%) | 16 (76.19%) | 18 (85.71%) | | Type 4 (%) | 5 (23.81%) | 3 (14.29%) | | Mean body surface involved (mean ± SD) | 30.5 ± 10.5 | 35.5 ± 11.5 | | Anatomical | | | | Head and neck | 9 | 12 | | Trunk | 13 | 7 | | Upper limb (proximal) | 6 | 4 | | Upper limb (distal) | 8 | 6 | | Lower limb (proximal) | 5 | 6 | | Lower limb (distal) | 4 | 3 |
|
|
